Taipei Exchange - Delayed Quote TWD

NeoCore Technology Co., Ltd. (4131.TWO)

34.10
+0.10
+(0.29%)
At close: 11:27:39 AM GMT+8
Loading Chart for 4131.TWO
  • Previous Close 34.00
  • Open 34.10
  • Bid 34.10 x --
  • Ask 34.90 x --
  • Day's Range 34.10 - 34.80
  • 52 Week Range 26.90 - 45.80
  • Volume 14,047
  • Avg. Volume 88,537
  • Market Cap (intraday) 1.347B
  • Beta (5Y Monthly) 0.22
  • PE Ratio (TTM) --
  • EPS (TTM) -1.14
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company's products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers laboratory planning, design, and other services. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and changed its name to NeoCore Technology Co., Ltd. in July 2023. NeoCore Technology Co., Ltd. was founded in 1987 and is headquartered in Tainan, Taiwan.

www.neocore.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4131.TWO

View More

Performance Overview: 4131.TWO

Trailing total returns as of 5/28/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

4131.TWO
6.56%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
7.28%

1-Year Return

4131.TWO
8.25%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
2.29%

3-Year Return

4131.TWO
128.86%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
31.30%

5-Year Return

4131.TWO
202.85%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
95.15%

Compare To: 4131.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4131.TWO

View More

Valuation Measures

Annual
As of 5/27/2025
  • Market Cap

    1.34B

  • Enterprise Value

    1.39B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    11.49

  • Price/Book (mrq)

    4.55

  • Enterprise Value/Revenue

    12.02

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -38.88%

  • Return on Assets (ttm)

    -7.56%

  • Return on Equity (ttm)

    -15.34%

  • Revenue (ttm)

    115.36M

  • Net Income Avi to Common (ttm)

    -44.86M

  • Diluted EPS (ttm)

    -1.14

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    123.77M

  • Total Debt/Equity (mrq)

    50.70%

  • Levered Free Cash Flow (ttm)

    -44.44M

Research Analysis: 4131.TWO

View More

Company Insights: 4131.TWO

Research Reports: 4131.TWO

View More

People Also Watch